Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
European Cannabis Holdings (ECH) was a London-based investment and holding company that played a foundational role in the development of the European medical cannabis industry. The group established a comprehensive ecosystem encompassing market intelligence through Prohibition Partners, industry networking via Cannabis Europa, and clinical care through The Medical Cannabis Clinics. In 2020, ECH underwent a significant corporate restructuring, rebranding its healthcare and clinical operations as Lyphe Group. The company focused on overcoming regulatory and supply chain hurdles to provide patients with consistent access to cannabis-based medicinal products. Its legacy continues through its former subsidiaries, which remain leaders in the European cannabis data and healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on European Cannabis Holdings.